Press Release: PCC Partners with IMD Health

Press Release: PCC Partners with IMD Health

Pancreatic Cancer Canada and IMD Health Global announce partnership to improve the quality of patient education Toronto – July 21, 2022 Pancreatic Cancer Canada is pleased to announce an important new partnership with IMD Health. IMD Health is the largest digital...
ANNOUNCEMENT: PCC Welcomes New Leadership to Board of Directors

ANNOUNCEMENT: PCC Welcomes New Leadership to Board of Directors

PCC Welcomes New Leadership to Board of Directors Toronto – April 2022 Pancreatic Cancer Canada (PCC) is excited to announce the election of Jonathan Paul to the role of Chair and Chris Andrews to the role of Vice-Chair of our Board of Directors. Both Mr....
PASS-01 Announcement: A Message from Michelle Capobianco

PASS-01 Announcement: A Message from Michelle Capobianco

Today I am thrilled to announce the launch of our next landmark research investment, PASS-01: a clinical trial that will finally address the diverse nature of this disease and provide personalized treatment options for advanced pancreatic cancer patients. For over 40...